Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Oct 23 EFFECT Notice of effectiveness
- 10 Oct 23 424B3 Prospectus supplement
- 6 Oct 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
28 Sep 23 S-4 Registration of securities issued in business combination transactions
ZVRA similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-4 of Zevra Therapeutics, Inc. (f/k/a KemPharm, Inc.) of our report dated March 30, 2022, relating to the financial statements of KemPharm, Inc. for the year ended December 31, 2021, appearing in the Annual Report on Form 10-K of Zevra Therapeutics, Inc. for the year ended December 31, 2022.
We also consent to the reference to our firm under the heading “Experts” in such proxy statement/prospectus.
/S/ RSM US LLP
Orlando, Florida
September 28, 2023